PERSPECTIVE article
Front. Public Health
Sec. Infectious Diseases: Epidemiology and Prevention
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1623386
This article is part of the Research TopicChallenges in Reaching the UNAIDS 95-95-95 targets in Sub-Saharan Africa: Status, Innovations and Pathways ForwardView all 13 articles
Establishment of antiretroviral pediatric registry: efforts towards achieving the UNAIDS 95-95-95 targets in the Free State Province, South Africa
Provisionally accepted
Bukola Omotoso1*
Mukesh Dheda2
Joseph B Sempa1Elizabeth Tabane1Refuoe Baleni1Tshepang Jiane1Thabiso Mofokeng1- 1University of the Free State, Bloemfontein, South Africa
- 2National Department of Health, Pretoria, South Africa
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Globally, there are approximately 1•5 million children (0-14 years old) living with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), of which 90% are in sub-Saharan Africa. South Africa has the most extensive pediatric HIV care and treatment program. Statistical data from 2023 demonstrated that 152,984 South African children (<15 years) were living with HIV. Despite the remarkable progress towards achieving the UNAIDS 95-95-95 targets in South African adults, the progress in the pediatric population seems to be lagging.HIV/AIDS remains a major factor in the morbidity and mortality of children. Some of the challenges impacting successful treatment outcomes include a high rate of loss to follow-up, virological non-suppression, and difficulties with treatment adherence as the children are reaching adulthood, indicating an urgent need for improved quality of care for children on antiretroviral therapy. The occurrence of adverse drug reactions (ADRs) is one of the problems affecting patient retention in treatment and is associated with an increased risk of incomplete viral suppression. To address these issues, strengthening spontaneous ADR reporting among HIV-infected pediatric patients at healthcare facilities has contributed to developing strategies for the prediction, identification, reporting, and prevention of ADR occurrence. In addition, establishing the ARV-Pediatric Registry has improved the quality of care for children on ART by enabling timely interventions and monitoring the effectiveness and safety of ART. These initiatives will help to address the specific challenges associated with reaching the 95-95-95 targets and provide a pathway forward for sustainable healthcare delivery for this vulnerable population.
Keywords: Pediatric1, sub-Saharan Africa2, adverse drug reactions3, Viral Load4, Dolutegravir5, ARV-Pediatric Registry6, Lost to Follow-up7
Received: 05 May 2025; Accepted: 21 Jul 2025.
Copyright: © 2025 Omotoso, Dheda, Sempa, Tabane, Baleni, Jiane and Mofokeng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Bukola Omotoso, University of the Free State, Bloemfontein, South Africa
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.